FDA/CDC
News
Watchdog group demands removal of FDA leaders after aducanumab approval
“This decision is a disastrous blow to the agency’s credibility, public health, and the financial sustainability of the Medicare program,” critic...
Latest News
FDA approves controversial Alzheimer’s drug aducanumab (Aduhelm)
Approval was granted despite an FDA advisory panel recommendation not to approve the drug.
FDA/CDC
FDA okays new drug option for schizophrenia, bipolar I disorder
The FDA approved Lybalvi under the 505(b)(2) regulatory pathway based on data from 27 clinical studies.
FDA/CDC
FDA fast tracks testing of schizophrenia drug for impaired cognition
The breakthrough therapy designation and the initiation of phase 3 testing are based on results from a phase 2 clinical trial.
FDA/CDC
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
As CDC investigates rare, mostly mild cases of myocarditis in adolescents and young adults given the Pfizer or Moderna vaccine, AHA emphasizes...
FDA/CDC
CDC: Vaccinated? You don’t need a mask indoors
FDA/CDC
CDC recommends use of Pfizer’s COVID vaccine in 12- to 15-year-olds
ACIP voted 14-0 in favor of the safety and effectiveness of the vaccine in younger teens.
News from the FDA/CDC
FDA authorizes Pfizer COVID vaccine for teens 12-15
FDA/CDC
FDA set to okay Pfizer vaccine in younger teens
FDA/CDC
FDA OKs higher-dose naloxone nasal spray for opioid overdose
Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of naloxone contained in Narcan.
FDA/CDC
CDC guidelines coming on long COVID